About Key Biologics, LLC

Who We Are

Key Biologics LLC is a privately owned, institutionally financed business headquartered in Memphis, TN. Together with its antecedent organizations, Key has provided research and clinical grade cell therapy cells and blood products and services to pharmaceutical, biotech, medical device and academic institutions around the world for more than ten years.

What We Do

Key provides unique and high-value human-derived biomaterials (cells and blood components), derived from human blood, umbilical cord, and bone marrow, along with the esoteric development and support services essential to successful research and clinical stage cell therapy. Our customers are some of the most recognized firms in life sciences and include developers of devices, drugs, and cell therapies as well as a wide variety of life science researchers.

Our Goal

Key's goal and our clients’ goals are the same: To advance life science from discovery, through R&D and into curing disease.

What We Bring to Clients

• Over a decade of experience in collecting and delivering human-derived biological materials to the life science industry.

• Continuity of source provider starting from pre-clinical research, through all phases of clinical trials, and into post-market commercial production.

• Collections of clinical-grade raw materials per customer-specification.

• Extensive donor network to ensure rapid collection from even the most unique donor types at dispersed sites around North America.

• Expertise in developing and submitting research protocols to IRBs on behalf of customers, gaining approval for such studies, and completing them in a timely and cost-effective manner.

• Extensive training and competence in matters regarding the safety and protection of donors
  

Partnership with Key

We believe that combining Key’s focus with that of our clients makes winning partnerships. Partnerships begin with a community of interests; for Key and our clients, this is the interest we share in advancing the development and commercialization of biotherapeutics.

Partnerships succeed based on the complementary talents each partner brings to the relationship. Key’s contribution is its experience helping develop, provision and/or manage hundreds of cell therapy projects. Quite simply, Key saves its customers the trouble and expense of creating their own cell sourcing capability including the professional staff, specialized equipment, donor data base, licensure and the know how necessary to design and manage projects that achieve their designated endpoints on time and on budget.

Our clients bring to each partnership an extraordinary body of scientific, biologic and operational knowledge that defines the therapy or device to be developed, which frequently will have a first-in-human application.

By working in partnership, each party is able to focus in its core competence and operate at its highest potential. As a result, progress is expedited and the promise of your biotherapeutic is closer to realization.